衞生事務範疇

規管機制

《預防及控制疾病（使用疫苗）規例》（第599K章）下認可疫苗的審批

政府訂立《預防及控制疾病（使用疫苗）規例》

2019冠狀病毒病疫苗顧問專家委員會成員名單

(84KB)

Guidance for Applications for Authorization of Vaccines under the Prevention and Control of Disease (Use of Vaccines) Regulation (Cap. 599K)

（只備英文版）(417KB)

Report on Evaluation by Advisory Panel on COVID-19 Vaccines

Report on Evaluation of Safety, Efficacy and Quality of Comirnaty COVID-19 mRNA Vaccine (BNT162b2) Concentrate for Dispersion for Injection（只備英文版）(2MB)
Report on Evaluation of Safety, Efficacy and Quality of CoronaVac COVID-19 Vaccine (Vero Cell) Inactivated（只備英文版）(533KB)

Brief summary update on COVID-19 Vaccines endorsed by Advisory Panel

Brief Summary Update on CoronaVac COVID-19 Vaccine (Vero Cell), Inactivated (30 September 2021)（只備英文版）(72KB)
Brief Summary Update on CoronaVac COVID-19 Vaccine (Vero Cell), Inactivated （2021年7月14日）（只備英文版）(22KB)
Brief Summary Update on CoronaVac COVID-19 Vaccine (Vero Cell), Inactivated （2021年4月29日）（只備英文版）(351KB)
Brief Summary Update on Comirnaty COVID-19 mRNA Vaccine (BNT162b2) Concentrate for Dispersion for Injection (30 September 2021)（只備英文版）(23KB)
Brief Summary Update on Comirnaty COVID-19 mRNA Vaccine (BNT162b2) Concentrate for Dispersion for Injection （2021年7月14日）（只備英文版）(38KB)
Brief Summary Update on Comirnaty COVID-19 mRNA Vaccine (BNT162b2) Concentrate for Dispersion for Injection （2021年4月29日）（只備英文版）(385KB)

說明書

2021年11月23日